Camrelizumab Utilization on Patients With Advanced Liver Cancer
Clinical trial NCT04487704 · UNKNOWN
Trial details
- NCT number
- NCT04487704
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-07
- Primary completion
- 2023-01-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.